Vandetanib is a tyrosine kinase inhibitor used in cancer treatment, particularly for advanced or metastatic medullary thyroid cancer. It works by inhibiting multiple receptor tyrosine kinases, including VEGFR, EGFR, and RET, which play a crucial role in tumor growth and angiogenesis. Due to its complex pharmacological nature, the production of vandetanib involves sophisticated chemical processes and stringent regulatory compliance. This report delves into the detailed production process of vandetanib, providing insights into the synthesis, manufacturing, and quality control aspects.
Overview of Vandetanib
Vandetanib, with the chemical formula C22H24BrFN4O2, is a white to slightly yellow powder that is highly potent in its anti-cancer activities. It is marketed under the trade name Caprelsa and is classified under targeted cancer therapies, making it a crucial drug for patients who do not respond to traditional treatments.
Request For Sample: https://www.procurementresource.com/production-cost-report-store/vandetanib/request-sample
Key Steps in Vandetanib Production Process
1. Raw Material Sourcing
The production of vandetanib begins with the sourcing of high-purity raw materials. Key chemicals such as bromofluoroaniline, pyrimidine derivatives, and intermediates required for coupling reactions are procured from certified vendors to ensure the final product’s purity and effectiveness. Stringent quality checks are performed to meet regulatory standards.
2. Synthesis of Key Intermediate: 4-Bromo-2-fluoroaniline
The production process starts with the synthesis of the crucial intermediate, 4-bromo-2-fluoroaniline, through halogenation and amination reactions. This intermediate is essential in the development of the core structure of vandetanib.
Step 1: Halogenation Reaction
In this step, a suitable aromatic ring is treated with bromine to introduce the bromo group at the para position of the ring. The presence of catalysts like aluminum chloride or iron bromide helps promote the reaction under controlled temperature and pressure.
Step 2: Fluorination
Following bromination, the compound undergoes selective fluorination at the ortho position using reagents like fluorine gas or fluorinating agents. This reaction is carefully controlled to ensure that only the ortho position is fluorinated, as improper control can lead to undesired by-products.
3. Coupling Reactions: Formation of Core Structure
After synthesizing the key intermediate, the next stage involves coupling 4-bromo-2-fluoroaniline with a pyrimidine derivative. This is achieved through a palladium-catalyzed cross-coupling reaction, specifically a Suzuki coupling, which links the aromatic aniline with the pyrimidine ring. This step forms the backbone of the vandetanib molecule, ensuring the proper arrangement of the active pharmacophore.
Key Parameters:
- Use of palladium as a catalyst
- Solvent: Toluene or dimethylformamide (DMF)
- Base: Potassium carbonate or sodium carbonate
- Temperature: 100-120°C
4. Nitrile Formation: Introduction of the CN Group
Once the core structure is formed, a nitrile group (CN) is introduced to the molecule. This step involves a substitution reaction using cyanogen bromide or another nitrile donor. The reaction is carefully monitored to avoid unwanted side reactions, as nitrile groups are highly reactive.
Key Parameters:
- Reagents: Cyanogen bromide, phase-transfer catalysts
- Solvent: Acetonitrile or ethanol
- Temperature: 60-80°C
5. Oxidation and Bromination of Pyrimidine Ring
The pyrimidine ring undergoes selective bromination and oxidation steps to create the necessary functional groups that allow vandetanib to act as an effective tyrosine kinase inhibitor. These steps are crucial for modulating the molecule’s bioactivity and selectivity towards VEGFR, EGFR, and RET.
Key Parameters:
- Bromination: N-bromosuccinimide (NBS)
- Solvent: Dichloromethane or chloroform
- Oxidation: Potassium permanganate or a similar oxidizing agent
6. Purification and Crystallization
After the desired molecular structure is obtained, vandetanib is subjected to rigorous purification processes, including recrystallization and filtration. These steps are essential to remove any impurities, ensuring the drug meets the required pharmacological standards. The product is recrystallized using solvents like ethanol or methanol to achieve a highly pure crystalline form of vandetanib.
Key Parameters:
- Filtration: Using activated charcoal to remove impurities
- Recrystallization: Solvents like methanol or ethanol
- Temperature: Room temperature to -10°C
7. Drying and Milling
The purified vandetanib crystals are dried using vacuum ovens to remove residual solvents. After drying, the product is milled into a fine powder, which is essential for ensuring consistent dosage forms when the drug is formulated into tablets or capsules.
8. Final Quality Control
Before packaging, the vandetanib undergoes stringent quality control measures to ensure that it meets the required purity, potency, and safety profiles. Analytical techniques like high-performance liquid chromatography (HPLC), mass spectrometry, and nuclear magnetic resonance (NMR) are employed to verify the structural integrity and purity of the product. Any batch that does not meet the specifications is discarded or reprocessed.
Key Analytical Techniques:
- HPLC for purity and potency checks
- Mass spectrometry for molecular weight determination
- NMR for structural verification
Environmental and Safety Considerations
The production of vandetanib involves the use of hazardous chemicals like bromine, fluorine, and cyanogen bromide, which require strict adherence to safety protocols. Waste management systems must be in place to handle the disposal of hazardous by-products. Environmental safety regulations dictate that waste materials undergo neutralization and proper disposal to avoid contamination.
The production of vandetanib is a multi-step, highly regulated process involving complex chemical reactions and rigorous quality control measures. Ensuring the drug’s high purity and efficacy requires a well-coordinated effort from sourcing raw materials to final packaging. Vandetanib’s production underscores the importance of precision, safety, and innovation in the pharmaceutical industry, contributing to its role as a vital cancer treatment option.
Contact Us:
Company Name: Procurement Resource
Contact Person: Endru Smith
Email: sales@procurementresource.com
Toll-Free Number: USA & Canada - Phone no: +1 307 363 1045 | UK - Phone no: +44 7537 132103 | Asia-Pacific (APAC) - Phone no: +91 1203185500
Address: 30 North Gould Street, Sheridan, WY 82801, USA
Famous Hindi 